search
close_mark

Pradeep Gangavaram

Pradeep Gangavaram

23 Jun, 2025

With 20+ years of Pharmaceutical industry experience across Drug Discovery, Regulatory Affairs, and Compliance, Pradeep is a system and business process owner leading our Pharma division delivery teams.

Pradeep holds a Masters degree in Biotechnology from Bangalore University.

Established a Regulatory Operations team for Consumer Health business unit Spearheaded several RIM/eDMS and publishing system migrations Successfully managed xEVMPD integration into P&G Healthcare business unit Led business process harmonization and digitization activities for raw materials documentation and its compliance Co-chaired IDMP office.

Maikel Bouman
Read Now

Other Related Articles

Beyond Document Delivery: How a Compliance-First CER Strategy Helped Achieve a Successful Notified Body Review
Blog Medical Devices

Beyond Document Delivery: How a Compliance-First CER Strategy Helped Achieve a Successful Notified Body Review

22 Jul, 2026

Responsible Integration of Artificial Intelligence in Clinical Evaluation Reports
Blog Medical Devices

Responsible Integration of Artificial Intelligence in Clinical Evaluation Reports

21 Jul, 2026

Navigating the Nagoya Protocol in Pharmaceutical Regulatory Affairs
Blog Pharmaceutical

Navigating the Nagoya Protocol in Pharmaceutical Regulatory Affairs

15 Jul, 2026

Companion Diagnostic Studies Under IVDR: Regulatory Requirements, Study Design, and Clinical Evidence Generation
Blog Medical Devices

Companion Diagnostic Studies Under IVDR: Regulatory Requirements, Study Design, and Clinical Evidence Generation

08 Jul, 2026

Beyond “Inactive”: Mastering Type IV DMFs for Excipients Using IPEC Guidance
Blog Pharmaceutical

Beyond “Inactive”: Mastering Type IV DMFs for Excipients Using IPEC Guidance

02 Jul, 2026

Ethylene Oxide in Pharmaceuticals and Consumer products – Essential Intermediate, High-Risk Exposure – A Regulatory Deep Dive
Blog Pharmaceutical

Ethylene Oxide in Pharmaceuticals and Consumer products – Essential Intermediate, High-Risk Exposure – A Regulatory Deep Dive

26 Jun, 2026

How to Address Data Consistency Challenges in EU MDR Submissions: A CAPTIS® Perspective
Blog Medical Devices

How to Address Data Consistency Challenges in EU MDR Submissions: A CAPTIS® Perspective

17 Jun, 2026

From Supplier to Label: Mastering Allergen Statements in Drugs and Cosmetics
Blog Pharmaceutical

From Supplier to Label: Mastering Allergen Statements in Drugs and Cosmetics

05 Jun, 2026

View All